
    
      Each participant will receive 3 doses of 1 of 3 lots of the investigational hexavalent
      vaccine or the control vaccine, Infanrix hexa™, administered with Prevenar™ at 2, 4, and 6
      months of age and Rotarix™ at 2 and 4 months of age.

      All participants will be monitored for safety for 6 months after the last injection of the
      primary vaccination series.
    
  